Roche is offering an outstanding opportunity for a Predictive Safety Analyst with expertise in genetic toxicology to design and execute preclinical models to support prioritization and de-risking of novel therapeutic agents throughout the drug discovery and development process. The predictive safety analyst is accountable for the scientific and operational delivery of modern regulated and non-regulated genetic toxicology assays to inform risk assessment of discovery and development projects. In this role, you will also drive the design, execution and development of advanced methods in genetic toxicology (eg., for novel modalities such as cell and gene therapy) and the application of these to inform decision-making. In addition to regular genetic toxicology assays, other similar assays are in scope, e.g. phototoxicity. This position will work closely with stakeholders from several disciplines including toxicology project leaders, small molecule research, DMPK, and immunosafety.
At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, they’ve become one of the world’s leading research-focused healthcare groups. Their success is built on innovation, curiosity and diversity. Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research.
For more information, please visit Predictive Safety Analyst – Genetic Toxicology in Basel, Basel-City, Switzerland | Research & Development at Roche
